Microbiome Therapeutics Market Report

Global and Region Microbiome Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：185
  • REPORT CODE：GMM1012349
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

    The report details the trend, potential and market size of Microbiome Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Microbiome Therapeuticsmarket, defines the market attractiveness level of Microbiome Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Microbiome Therapeutics industry, describes the types of Microbiome Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Microbiome Therapeutics market and the development prospects and opportunities of Microbiome Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Microbiome Therapeutics market in Chapter 13.

    By Player:

    • AOBiome

    • Rebiotix

    • Synlogic

    • Azitra

    • Seres Therapeutics

    • OpenBiome

    • Metabiomics

    • C3 Jian

    • PureTech

    • Enterome BioScience

    • Symberix

    • Synthetic Biologics

    • Second Genome

    • Interxon

    • Symbiotix Biotherapies

    • MicroBiome Therapeutics LLC

    • Metabogen

    • Ritter Pharmaceuticals

    • Osel

    • 4D Pharma

    • Assembly Biosciences

    By Type:

    • Inflammatory Bowel Disease (IBD)

    • Orphan Drug

    • Immuno-oncology

    • Others

    By End-User:

    • Inflammatory Bowel Disease (IBD)

    • Orphan Drug

    • Immuno-oncology

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Microbiome Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Microbiome Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Microbiome Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Microbiome Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Microbiome Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Microbiome Therapeutics Consumption (2017-2022)

    • 7.2 United States Microbiome Therapeutics Consumption (2017-2022)

    • 7.3 Europe Microbiome Therapeutics Consumption (2017-2022)

    • 7.4 China Microbiome Therapeutics Consumption (2017-2022)

    • 7.5 Japan Microbiome Therapeutics Consumption (2017-2022)

    • 7.6 India Microbiome Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Microbiome Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Microbiome Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Microbiome Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Microbiome Therapeutics Consumption Forecast (2022-2028)

    9 Global Microbiome Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Microbiome Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Orphan Drug Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immuno-oncology Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Microbiome Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Orphan Drug Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Immuno-oncology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Microbiome Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Microbiome Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Orphan Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immuno-oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Microbiome Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Orphan Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Immuno-oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Microbiome Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Microbiome Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Microbiome Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Microbiome Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Microbiome Therapeutics Market Competitive Analysis

    • 14.1 AOBiome

      • 14.1.1 AOBiome Company Details

      • 14.1.2 AOBiome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AOBiome Microbiome Therapeutics Product and Service

    • 14.2 Rebiotix

      • 14.2.1 Rebiotix Company Details

      • 14.2.2 Rebiotix Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Rebiotix Microbiome Therapeutics Product and Service

    • 14.3 Synlogic

      • 14.3.1 Synlogic Company Details

      • 14.3.2 Synlogic Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Synlogic Microbiome Therapeutics Product and Service

    • 14.4 Azitra

      • 14.4.1 Azitra Company Details

      • 14.4.2 Azitra Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Azitra Microbiome Therapeutics Product and Service

    • 14.5 Seres Therapeutics

      • 14.5.1 Seres Therapeutics Company Details

      • 14.5.2 Seres Therapeutics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Seres Therapeutics Microbiome Therapeutics Product and Service

    • 14.6 OpenBiome

      • 14.6.1 OpenBiome Company Details

      • 14.6.2 OpenBiome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 OpenBiome Microbiome Therapeutics Product and Service

    • 14.7 Metabiomics

      • 14.7.1 Metabiomics Company Details

      • 14.7.2 Metabiomics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Metabiomics Microbiome Therapeutics Product and Service

    • 14.8 C3 Jian

      • 14.8.1 C3 Jian Company Details

      • 14.8.2 C3 Jian Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 C3 Jian Microbiome Therapeutics Product and Service

    • 14.9 PureTech

      • 14.9.1 PureTech Company Details

      • 14.9.2 PureTech Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 PureTech Microbiome Therapeutics Product and Service

    • 14.10 Enterome BioScience

      • 14.10.1 Enterome BioScience Company Details

      • 14.10.2 Enterome BioScience Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Enterome BioScience Microbiome Therapeutics Product and Service

    • 14.11 Symberix

      • 14.11.1 Symberix Company Details

      • 14.11.2 Symberix Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Symberix Microbiome Therapeutics Product and Service

    • 14.12 Synthetic Biologics

      • 14.12.1 Synthetic Biologics Company Details

      • 14.12.2 Synthetic Biologics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Synthetic Biologics Microbiome Therapeutics Product and Service

    • 14.13 Second Genome

      • 14.13.1 Second Genome Company Details

      • 14.13.2 Second Genome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Second Genome Microbiome Therapeutics Product and Service

    • 14.14 Interxon

      • 14.14.1 Interxon Company Details

      • 14.14.2 Interxon Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Interxon Microbiome Therapeutics Product and Service

    • 14.15 Symbiotix Biotherapies

      • 14.15.1 Symbiotix Biotherapies Company Details

      • 14.15.2 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Symbiotix Biotherapies Microbiome Therapeutics Product and Service

    • 14.16 MicroBiome Therapeutics LLC

      • 14.16.1 MicroBiome Therapeutics LLC Company Details

      • 14.16.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Service

    • 14.17 Metabogen

      • 14.17.1 Metabogen Company Details

      • 14.17.2 Metabogen Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Metabogen Microbiome Therapeutics Product and Service

    • 14.18 Ritter Pharmaceuticals

      • 14.18.1 Ritter Pharmaceuticals Company Details

      • 14.18.2 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Ritter Pharmaceuticals Microbiome Therapeutics Product and Service

    • 14.19 Osel

      • 14.19.1 Osel Company Details

      • 14.19.2 Osel Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Osel Microbiome Therapeutics Product and Service

    • 14.20 4D Pharma

      • 14.20.1 4D Pharma Company Details

      • 14.20.2 4D Pharma Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 4D Pharma Microbiome Therapeutics Product and Service

    • 14.21 Assembly Biosciences

      • 14.21.1 Assembly Biosciences Company Details

      • 14.21.2 Assembly Biosciences Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Assembly Biosciences Microbiome Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Microbiome Therapeutics

    • Figure Microbiome Therapeutics Picture

    • Table Global Microbiome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Microbiome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Microbiome Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Microbiome Therapeutics Consumption by Country (2017-2022)

    • Figure United States Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Microbiome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Microbiome Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)

    • Figure Global Orphan Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Immuno-oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)

    • Figure Global Orphan Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Immuno-oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orphan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immuno-oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orphan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immuno-oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Microbiome Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Microbiome Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table AOBiome (Foundation Year, Company Profile and etc.)

    • Table AOBiome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AOBiome Microbiome Therapeutics Product and Service

    • Table Rebiotix (Foundation Year, Company Profile and etc.)

    • Table Rebiotix Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rebiotix Microbiome Therapeutics Product and Service

    • Table Synlogic (Foundation Year, Company Profile and etc.)

    • Table Synlogic Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synlogic Microbiome Therapeutics Product and Service

    • Table Azitra (Foundation Year, Company Profile and etc.)

    • Table Azitra Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Azitra Microbiome Therapeutics Product and Service

    • Table Seres Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seres Therapeutics Microbiome Therapeutics Product and Service

    • Table OpenBiome (Foundation Year, Company Profile and etc.)

    • Table OpenBiome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table OpenBiome Microbiome Therapeutics Product and Service

    • Table Metabiomics (Foundation Year, Company Profile and etc.)

    • Table Metabiomics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Metabiomics Microbiome Therapeutics Product and Service

    • Table C3 Jian (Foundation Year, Company Profile and etc.)

    • Table C3 Jian Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table C3 Jian Microbiome Therapeutics Product and Service

    • Table PureTech (Foundation Year, Company Profile and etc.)

    • Table PureTech Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table PureTech Microbiome Therapeutics Product and Service

    • Table Enterome BioScience (Foundation Year, Company Profile and etc.)

    • Table Enterome BioScience Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enterome BioScience Microbiome Therapeutics Product and Service

    • Table Symberix (Foundation Year, Company Profile and etc.)

    • Table Symberix Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Symberix Microbiome Therapeutics Product and Service

    • Table Synthetic Biologics (Foundation Year, Company Profile and etc.)

    • Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthetic Biologics Microbiome Therapeutics Product and Service

    • Table Second Genome (Foundation Year, Company Profile and etc.)

    • Table Second Genome Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Second Genome Microbiome Therapeutics Product and Service

    • Table Interxon (Foundation Year, Company Profile and etc.)

    • Table Interxon Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Interxon Microbiome Therapeutics Product and Service

    • Table Symbiotix Biotherapies (Foundation Year, Company Profile and etc.)

    • Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Symbiotix Biotherapies Microbiome Therapeutics Product and Service

    • Table MicroBiome Therapeutics LLC (Foundation Year, Company Profile and etc.)

    • Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Service

    • Table Metabogen (Foundation Year, Company Profile and etc.)

    • Table Metabogen Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Metabogen Microbiome Therapeutics Product and Service

    • Table Ritter Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ritter Pharmaceuticals Microbiome Therapeutics Product and Service

    • Table Osel (Foundation Year, Company Profile and etc.)

    • Table Osel Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Osel Microbiome Therapeutics Product and Service

    • Table 4D Pharma (Foundation Year, Company Profile and etc.)

    • Table 4D Pharma Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table 4D Pharma Microbiome Therapeutics Product and Service

    • Table Assembly Biosciences (Foundation Year, Company Profile and etc.)

    • Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Assembly Biosciences Microbiome Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US